YKP-1358 Uses, Dosage, Side Effects and more

YKP1358 is a novel serotonin (5-HT2A) and dopamine (D2) antagonist that has demonstrated potent activity in animals that relates to both positive and negative symptoms of schizophrenia. In addition, the YKP1358 pharmacological profile suggests a very low potential for extrapyramidal side effects.

Trade Name YKP-1358
Generic YKP-1358
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in schizophrenia and schizoaffective disorders.

How YKP-1358 works

serotonin (5-HT2A) and dopamine (D2) antagonist.

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share